BETEL-NUT-ASSOCIATED ORAL CARCINOMA

Clinical trials for BETEL-NUT-ASSOCIATED ORAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new BETEL-NUT-ASSOCIATED ORAL CARCINOMA trials appear

Sign up with your email to follow new studies for BETEL-NUT-ASSOCIATED ORAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can immunotherapy shrink Betel-Nut oral tumors before surgery?

Disease control Not yet recruiting

This trial tests whether giving two immunotherapy drugs—pembrolizumab and cetuximab—before surgery can shrink advanced oral cancers linked to betel-nut chewing. The study enrolls 20 people in the Northern Mariana Islands who have not yet received treatment. Researchers will measu…

Matched conditions: BETEL-NUT-ASSOCIATED ORAL CARCINOMA

Phase: PHASE2 • Sponsor: Peter Brett, MD • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

BETEL-NUT-ASSOCIATED ORAL CARCINOMA

Get alerted when new BETEL-NUT-ASSOCIATED ORAL CARCINOMA trials appear

Can immunotherapy shrink Betel-Nut oral tumors before surgery?